Endo International | ENDP - Srodki Pieniężne I Ekwiwalent



Srodki Pieniężne I Ekwiwalent Zmiana Data
AbbVie USD 9.39B 4.16B 2026-03
Amarin USD 131.06M 3.6M 2026-03
ANI Pharmaceuticals USD 311.18M 25.59M 2026-03
Bristol-Myers Squibb USD 9.57B 635M 2026-03
Coherus Biosciences USD 88.88M 14.47M 2025-12
Eli Lilly USD 5.28B 1.99B 2026-03
Heron Therapeutics USD 26.12M 2.53M 2026-03
Hikma Pharmaceutical USD 236M 48M 2025-06
Ligand Pharmaceuticals USD 115.08M 59.85M 2026-03
Merck USD 5.33B 9.24B 2026-03
Novartis USD 6.88B 4.56B 2026-03
Pacira USD 144.31M 14.24M 2026-03
Perrigo USD 531.6M 99.5M 2025-12
Pfizer USD 1.7B 561M 2026-03
Phibro Animal Health USD 54.93M 557K 2026-03
Supernus Pharmaceuticals USD 184.87M 56.42M 2026-03
Takeda JPY 654.94B 26.55B 2025-12
Teva Pharmaceutical Industries USD 3.56B 1.35B 2025-12
Xeris Pharmaceuticals USD 111.75M 708K 2026-03
Zoetis USD 1.94B 369M 2026-03